AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.27B
1-Year Est. Return 22.51%
This Quarter Est. Return
1 Year Est. Return
+22.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.17B
AUM Growth
+$261M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,406
New
Increased
Reduced
Closed

Top Buys

1 +$8.54M
2 +$4.59M
3 +$4.08M
4
OKTA icon
Okta
OKTA
+$3.24M
5
APG icon
APi Group
APG
+$2.41M

Top Sells

1 +$5.39M
2 +$4.09M
3 +$3.05M
4
BERY
Berry Global Group, Inc.
BERY
+$2.11M
5
X
US Steel
X
+$1.87M

Sector Composition

1 Technology 23.69%
2 Industrials 9.88%
3 Financials 9.71%
4 Consumer Discretionary 9.42%
5 Healthcare 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSST icon
3176
Return Stacked US Stocks & Managed Futures ETF
RSST
$283M
$23 ﹤0.01%
+1
PCEF icon
3177
Invesco CEF Income Composite ETF
PCEF
$840M
$18 ﹤0.01%
+1
UMC icon
3178
United Microelectronic
UMC
$17.8B
$15 ﹤0.01%
2
DGRW icon
3179
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
0
GREE icon
3180
Greenidge Generation Holdings
GREE
$24.3M
$6 ﹤0.01%
5
QGRO icon
3181
American Century US Quality Growth ETF
QGRO
$2.02B
0
AKA icon
3182
a.k.a. Brands
AKA
$134M
-61
AKYA
3183
DELISTED
Akoya BioSciences
AKYA
-1,199
ALXO icon
3184
ALX Oncology
ALXO
$66.1M
-2,790
AMPY icon
3185
Amplify Energy
AMPY
$230M
-2,675
AMTX icon
3186
Aemetis
AMTX
$130M
-3,550
APLT icon
3187
Applied Therapeutics
APLT
$55.2M
-9,419
JSPR icon
3188
Jasper Therapeutics
JSPR
$46.2M
-1,109
JWN
3189
DELISTED
Nordstrom
JWN
-19,160
KNSA icon
3190
Kiniksa Pharmaceuticals
KNSA
$3.08B
-3,649
LCTX icon
3191
Lineage Cell Therapeutics
LCTX
$424M
-10,656
LCUT icon
3192
Lifetime Brands
LCUT
$74.5M
-1,219
LESL icon
3193
Leslie's
LESL
$28.6M
-883
LNZA icon
3194
LanzaTech
LNZA
$41.1M
-110
LSEA
3195
DELISTED
Landsea Homes
LSEA
-2,092
LVO icon
3196
LiveOne
LVO
$54.6M
-667
LWLG icon
3197
Lightwave Logic
LWLG
$659M
-11,312
LXRX icon
3198
Lexicon Pharmaceuticals
LXRX
$527M
-8,867
LYEL icon
3199
Lyell Immunopharma
LYEL
$327M
-856
ARTV
3200
Artiva Biotherapeutics
ARTV
$90.1M
-1,424